Literature DB >> 11795464

The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping, and hope.

S G Lynch1, D C Kroencke, D R Denney.   

Abstract

The relationship between disability and depression was studied in 188 patients with clinically definite multiple sclerosis (MS). Patients were administered the Zung Self-Rating Depression Scale, Ways of Coping, Uncertainty of Illness Scale, and Hope Scale during their regular clinic appointments. Their current level of disability was rated by the attending physician using the Expanded Disability Status Scale. Even when the depression measure was corrected for items overlapping with other symptoms or consequences of MS, depression was correlated with disability. Depression was also correlated with an array of psychological variables, including uncertainty concerning ones illness, hope, and the use of various emotion-centered, though not problem-centered coping strategies. Multiple regression analyses revealed that none of these psychological correlates mediated or moderated the relationship between disability and depression. Instead, disability, uncertainty, hope, and emotion-centered coping were significant independent predictors of depression, together accounting for approximately 40% of the variance in patients' self-reported depression. The relationship between disability and depression in MS is usually interpreted as evidence that depression is psychogenic and reactive to the demands and limitations of this disease. The demonstration that this relationship is not diminished when an array of potentially intervening psychological variables are included in the analysis raises questions concerning the validity of this interpretation.

Entities:  

Mesh:

Year:  2001        PMID: 11795464     DOI: 10.1177/135245850100700611

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  37 in total

Review 1.  Psychosocial Adaptation to Disability Within the Context of Positive Psychology: Findings from the Literature.

Authors:  Erin Martz; Hanoch Livneh
Journal:  J Occup Rehabil       Date:  2016-03

2.  Psychometric properties of the Hamilton Depression Rating Scale in multiple sclerosis.

Authors:  Simona Raimo; Luigi Trojano; Daniele Spitaleri; Vittorio Petretta; Dario Grossi; Gabriella Santangelo
Journal:  Qual Life Res       Date:  2015-02-11       Impact factor: 4.147

3.  Neuropsychiatric manifestations of multiple sclerosis.

Authors:  Laura C Politte; Jeff C Huffman; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

4.  Improving the quality of life of multiple sclerosis patients through coping strategies in routine medical practice.

Authors:  Richard Devy; Philippe Lehert; Etienne Varlan; Marc Genty; Gilles Edan
Journal:  Neurol Sci       Date:  2014-07-27       Impact factor: 3.307

5.  Relationship between disease-modifying therapy and depression in multiple sclerosis.

Authors:  Stephen S Kirzinger; Jason Jones; Angela Siegwald; Andrew Bryce Crush
Journal:  Int J MS Care       Date:  2013

6.  Multiple sclerosis: Treatment of cognitive impairment in secondary progressive MS.

Authors:  Anthony Feinstein
Journal:  Nat Rev Neurol       Date:  2017-07-28       Impact factor: 42.937

7.  Coping, uncertainty and health-related quality of life as determinants of anxiety and depression on a sample of hospitalized cardiac patients in Southern Italy.

Authors:  Maria Daniela Giammanco; Lara Gitto
Journal:  Qual Life Res       Date:  2016-05-31       Impact factor: 4.147

8.  The stress-buffering effects of hope on adjustment to multiple sclerosis.

Authors:  Sindia Madan; Kenneth I Pakenham
Journal:  Int J Behav Med       Date:  2014-12

9.  Measuring hope among families impacted by cognitive impairment.

Authors:  Amanda E Hunsaker; Lauren Terhorst; Amanda Gentry; Jennifer H Lingler
Journal:  Dementia (London)       Date:  2014-04-29

10.  The relevance of depressive symptoms and social support to disability in women with multiple sclerosis or fibromyalgia.

Authors:  Lorraine J Phillips; Alexa K Stuifbergen
Journal:  Int J Rehabil Res       Date:  2010-06       Impact factor: 1.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.